Jove
Visualize
お問い合わせ

関連する概念動画

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

34
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
34
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

43
 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

32
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
32
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

24
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
24
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー
  1. ホーム
  3. パクリタキセル誘発の周辺神経疾患と生活の質:michel研究によるサブ分析
  1. ホーム
  3. パクリタキセル誘発の周辺神経疾患と生活の質:michel研究によるサブ分析

関連する実験動画

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.3K

パクリタキセル誘発の周辺神経疾患と生活の質:MICHEL研究によるサブ分析

Aya Sawa1, Riko Sato1, Tomohei Matsuo1

  • 1Department of Breast-Thyroid-Endocrine Surgery, University of Tsukuba Hospital, Ibaraki, Japan.

Anticancer research
|August 28, 2025

PubMed で要約を見る

まとめ
この要約は機械生成です。

パクリタキセルによる化学療法による周辺神経症 (CIPN) は,日常活動に大きな影響を及ぼします. この研究ではミロガバリンは

キーワード:
化学療法による外周神経症乳がんミロガバリンパクリタキセル術後の化学療法

さらに関連する動画

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.0K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K

関連する実験動画

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
07:42

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

Published on: April 26, 2012

18.3K
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

10.0K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

9.6K

科学分野:

  • 腫瘍学
  • 神経学
  • 薬理学について

背景:

  • パクリタキセルは乳がんの一般的な化学療法で,化学療法による周辺神経症 (CIPN) を引き起こします.
  • CIPNは,患者の日常生活の活動を著しく阻害します.
  • MICHEL研究では,CIPNに対するミロガバリンの有効性を調査した.

研究 の 目的:

  • パクリタキセル治療を受けている乳がん患者の日常活動に対するCIPNの影響を分析する.
  • CIPNの進行を示す急性変化を特定する.
  • CIPNの日常生活への影響に関する患者報告のアンケートによる二次エンドポイントを評価する.

主な方法:

  • MICHEL試験試験の予期的な,単一アーム,オープンラベルのサブ分析.
  • パクリタキセル治療中のグレード2+CIPNの乳がん患者20人が登録されました.
  • 患者の神経毒性アンケートスコアと日常生活活動の中断を評価した.

主要な成果:

  • パクリタキセル誘発のCIPNは,特に細部運動能力 (例えば,服のボタン付け) と運動能力 (例えば,階段を登り,歩く) に影響した.
  • 5週目では,着物のボタン付け (55%),書くこと (45%),歩くこと (45%) が最も影響を受けた.
  • 日常活動が改善したと報告した患者もいます.

    • 結論:

    • パクリタキセル誘発のCIPNは,手機能と運動能力に大きく影響し,日常生活に影響を及ぼします.
    • ドゥロキセチンやリハビリテーションを含む個別化されたケア戦略は,CIPNの症状を管理するのに役立ちます.
    • ミロガバリンの有効性とCIPNの最適な管理を確認するには,さらなる研究が必要です.